Trial record 2 of 2 for:
vedolizumab adalimumab | ulcerative colitis | Italy
Entyvio (Vedolizumab) Long Term Safety Study (Entyvio PASS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02674308 |
|
Recruitment Status :
Active, not recruiting
First Posted : February 4, 2016
Last Update Posted : April 14, 2021
|
Sponsor:
Takeda
Information provided by (Responsible Party):
Takeda
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | July 30, 2021 |
| Estimated Study Completion Date : | July 30, 2021 |